IRF4 haploinsufficiency in a family with Whipple's disease
- INSERM U1163, France
- Sidra Medical and Research Center, Qatar
- The Rockefeller University, United States
- University Aix-Marseille (URMITE), France
- Garvan Institute of Medical Research, Australia
- Memorial Sloan Kettering Cancer Center, United States
- Institut Pasteur, France
- Cochin Hospital, France
- Imagine Institute, Paris Descartes University, France
Abstract
Most humans are exposed to Tropheryma whipplei (Tw). Whipple's disease (WD) strikes only a small minority of individuals infected with Tw (<0.01%), whereas asymptomatic chronic carriage is more common (<25%). We studied a multiplex kindred, containing four WD patients and five healthy Tw chronic carriers. We hypothesized that WD displays autosomal dominant (AD) inheritance, with age-dependent incomplete penetrance. We identified a single very rare non-synonymous mutation in the four patients: the private R98W variant of IRF4, a transcription factor involved in immunity. The five Tw carriers were younger, and also heterozygous for R98W. We found that R98W was loss-of-function, modified the transcriptome of heterozygous leukocytes following Tw stimulation, and was not dominant-negative. We also found that only six of the other 153 known non-synonymous IRF4 variants were loss-of-function. Finally, we found that IRF4 had evolved under purifying selection. AD IRF4 deficiency can underlie WD by haploinsufficiency, with age-dependent incomplete penetrance.
Data availability
-
IRF4 haplo-insufficiency underlies a familial form of Whipple's diseasePublicly available at the NCBI Gene Expression Omnibus (accession no: GSE102862).
Article and author information
Author details
Jean-Laurent Casanova
Funding
Centre National de la Recherche Scientifique
- Lluis Quintana-Murci
Agence Nationale de la Recherche (ANR-14-CE14-0008-02)
- Lluis Quintana-Murci
Agence Nationale de la Recherche (ANR-14-CE14-0007-02)
- Lluis Quintana-Murci
H2020 European Research Council
- Lluis Quintana-Murci
National Health and Medical Research Council (1113904)
- Stuart G Tangye
University of New South Wales
- Lisa Worley
- Tina Nguyen
Agence Nationale de la Recherche (ANR-16-CE17-0005-01)
- Antoine Guérin
National Institutes of Health (5R01AI089970-02)
- Jean-Laurent Casanova
National Health and Medical Research Council (1042925)
- Cindy S Ma
Office of Health and Medical Research
- Cindy S Ma
- Stuart G Tangye
H2020 European Research Council (281297)
- Lluis Quintana-Murci
- Jean-Laurent Casanova
Seventh Framework Programme (FP/2007-2013)
- Lluis Quintana-Murci
Agence Nationale de la Recherche (ANR-IFNPHOX (ANR-13-ISV3-001-01))
- Jacinta Bustamante
Agence Nationale de la Recherche (ANR-10-LABX-62-IBEID)
- Lluis Quintana-Murci
- Laurent Abel
- Jean-Laurent Casanova
Agence Nationale de la Recherche (ANR-GENMSMD (ANR-16-CE17-0005-01))
- Jacinta Bustamante
The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.
Ethics
Human subjects: Informed consent was obtained from all family members, and the study was approved by the national ethics committee.
Copyright
© 2018, Guérin et al.
This article is distributed under the terms of the Creative Commons Attribution License permitting unrestricted use and redistribution provided that the original author and source are credited.
Metrics
-
- 3,931
- views
-
- 506
- downloads
-
- 48
- citations
Views, downloads and citations are aggregated across all versions of this paper published by eLife.
Download links
A two-part list of links to download the article, or parts of the article, in various formats.
Downloads (link to download the article as PDF)
Open citations (links to open the citations from this article in various online reference manager services)
Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)
IRF4 haploinsufficiency in a family with Whipple's disease
eLife 7:e32340.
https://doi.org/10.7554/eLife.32340
Further reading
-
- Chromosomes and Gene Expression
- Immunology and Inflammation
Genome-wide association studies (GWAS) have identified hundreds of genetic signals associated with autoimmune disease. The majority of these signals are located in non-coding regions and likely impact cis-regulatory elements (cRE). Because cRE function is dynamic across cell types and states, profiling the epigenetic status of cRE across physiological processes is necessary to characterize the molecular mechanisms by which autoimmune variants contribute to disease risk. We localized risk variants from 15 autoimmune GWAS to cRE active during TCR-CD28 co-stimulation of naïve human CD4+ T cells. To characterize how dynamic changes in gene expression correlate with cRE activity, we measured transcript levels, chromatin accessibility, and promoter–cRE contacts across three phases of naive CD4+ T cell activation using RNA-seq, ATAC-seq, and HiC. We identified ~1200 protein-coding genes physically connected to accessible disease-associated variants at 423 GWAS signals, at least one-third of which are dynamically regulated by activation. From these maps, we functionally validated a novel stretch of evolutionarily conserved intergenic enhancers whose activity is required for activation-induced IL2 gene expression in human and mouse, and is influenced by autoimmune-associated genetic variation. The set of genes implicated by this approach are enriched for genes controlling CD4+ T cell function and genes involved in human inborn errors of immunity, and we pharmacologically validated eight implicated genes as novel regulators of T cell activation. These studies directly show how autoimmune variants and the genes they regulate influence processes involved in CD4+ T cell proliferation and activation.
-
- Cell Biology
- Immunology and Inflammation
Arpin was discovered as an inhibitor of the Arp2/3 complex localized at the lamellipodial tip of fibroblasts, where it regulated migration steering. Recently, we showed that arpin stabilizes the epithelial barrier in an Arp2/3-dependent manner. However, the expression and functions of arpin in endothelial cells (EC) have not yet been described. Arpin mRNA and protein are expressed in EC and downregulated by pro-inflammatory cytokines. Arpin depletion in Human Umbilical Vein Endothelial Cells causes the formation of actomyosin stress fibers leading to increased permeability in an Arp2/3-independent manner. Instead, inhibitors of ROCK1 and ZIPK, kinases involved in the generation of stress fibers, normalize the loss-of-arpin effects on actin filaments and permeability. Arpin-deficient mice are viable but show a characteristic vascular phenotype in the lung including edema, microhemorrhage, and vascular congestion, increased F-actin levels, and vascular permeability. Our data show that, apart from being an Arp2/3 inhibitor, arpin is also a regulator of actomyosin contractility and endothelial barrier integrity.
